Navigation Links
PDL BioPharma Provides Third Quarter 2009 Revenue Guidance of Approximately $71 Million
Date:9/8/2009

INCLINE VILLAGE, Nev., Sept. 8 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced revenue guidance for the third quarter ended September 30, 2009 of approximately $71 million, as compared with $69 million for the third quarter of 2008. Royalty revenues are based on second quarter product sales by PDL's licensees and include $1.6 million for Synagis(R), which is marketed by MedImmune. When compared with 2008, royalty revenue for foreign sourced sales was negatively impacted by changes in foreign exchange rates; approximately 50 percent of underlying product sales is in currencies other than U.S. dollars.

The above guidance is preliminary and actual published results may differ from such guidance. PDL plans to release its financial results for the third quarter 2009 on October 27, and will hold a conference call to discuss financial results and provide an update on company activities. Additional information regarding the call will be announced in late October.

About PDL BioPharma, Inc.

PDL BioPharma pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The company receives royalties on sales of a number of humanized antibody products marketed today and also may receive royalty payments on additional humanized antibody products launched before patent expiry in late 2014. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

Forward-looking Statements

This press release contains forward-looking
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Helix BioPharma Announces $13.5 Million Private Placement
2. Helix Biopharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
3. DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference
4. Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors
5. DOR BioPharma Reports 2nd Quarter and 1st Half 2009 Financial Results and Reviews Recent Accomplishments
6. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
7. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
8. Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford University
9. DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
10. PDL BioPharma to Present at BMO Capital Markets Healthcare Conference on August 5, 2009
11. Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., DURHAM,N.C.,Nov.25/PRNewswire/--ResearchTriangl...ent,single-treatmentwaterpurificationsystemNanoPur...inisterofRuralWaterSupply,Hon.MinisterViswarupando...formedatIndianInstituteofTechnology(IIT)Kanpur,con...Indiacontainstoxinsthatcanbeextremelyhazardoustohu...
(Date:11/25/2009)..., ,, BOCARATON,Fla.,Nov.25/PRNewswire/--For...yLogicMD.Thenation,slargestandfastestgrowingnetwor...llysupervised bioidenticalhormones has grownthenum...-from21to36physicians -andisinprogresstoaddmorephy...endofthisyear. ,, Inthepastyear ,BodyLogicMDhas...
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/--Reportlinker.comann...catalogue: ,, BrazilBioethanolMarketAnalysisan...om/p0165503/Brazil-Bioethanol-Market-Analysis-and-...etAnalysisandForecaststo2013 ,, Summary ,,...eglobalbioethanolmarketandtheBrazilbioethanolmarke...
(Date:11/24/2009)..., HOUSTON,Nov.24/PRNewswire-FirstCall/--IES(Nasda...ommunicationssystemsandservicesforthecommercial,in...scommercialbusinessgrouphasbeenawardedacontractfro...theLevel4bio-safetylab(BSL-4)replacementfacilityat...eases(USAMRIID)atFortDetrickinFrederick,Md. ,, ...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
...up, Inc. released its third TreatmentTrends(TM): ...allel to two ongoing studies BioTrends conducts --...y . The report is based on the results of an on-l... UK, Germany, France, Italy, and Spain. The focus...sphatemia. , , In the ESA market, Amgen,s Ara...
...y tip shapes,stand out in Terumo,s newest family o...announces the launch of Optitorque(TM), its,new li... exclusive Tiger and,Jacky tip shapes designed and..., "The Optitorque catheters, specially desig...he radial technique by reducing the learning curve...
...ressive radiology groups partners with AMICAS to e.... 1 AMICAS, Inc. (Nasdaq: AMCS ), a leader in r...ent solutions, today announced a new partnership w...s, St. Paul Radiology of St. Paul, MN. This partne...s aggressive growth initiatives while standardizin...
Other Biology Technology:European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTrends Report 2Terumo Interventional Systems Launches a Complete Line of Coronary Diagnostic Catheters 2Terumo Interventional Systems Launches a Complete Line of Coronary Diagnostic Catheters 3St. Paul Radiology Selects AMICAS 2St. Paul Radiology Selects AMICAS 3
(Date:11/24/2009)...hat constitutes fish food is a matter of debate. A... fish get almost 50 percent of their carbon from t...tween the terrestrial and aquatic ecosystems. , ... shows this is not likely to be true. Algae provid...fe, according to research published this week in t...
(Date:11/24/2009)...his release is available in Spanish . , The...her levels of inflammatory substances in the blood... as shown by a research project of the University ...a scientist at the School of Pharmacy. , The pro...udy in relation to the control of body weight and ...
(Date:11/23/2009)...shington, D.C. The community-associated strain of...eria resistant to most common antibioticsposes a f... is making its way into hospitals, according to a ...s Diseases . , The new threat is easily picked ...laces and has increased the overall burden of MRSA...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Las Vegas Plastic Surgery Center 28imagepluslasvegas com 29 Specializes in Non Surgical Cosmetic Procedures 60200 1Las Vegas Plastic Surgery Center 28imagepluslasvegas com 29 Specializes in Non Surgical Cosmetic Procedures 60200 2Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents According to Scientists at the Feinstein Institute for Medical Re 60196 1Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents According to Scientists at the Feinstein Institute for Medical Re 60196 2Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents According to Scientists at the Feinstein Institute for Medical Re 60196 3Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents According to Scientists at the Feinstein Institute for Medical Re 60196 4Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents According to Scientists at the Feinstein Institute for Medical Re 60196 5Nashboro Village Family Dental to Present First Annual Super Talent and All Star Show 60191 1Nashboro Village Family Dental to Present First Annual Super Talent and All Star Show 60191 2Nashboro Village Family Dental to Present First Annual Super Talent and All Star Show 60191 3
...ced and compared the genomes of planktonic microbe...c Ocean. The pioneering study yielded insight into...ch depth--ranging from 40 to more than 13,000 feet...mes of entire microbial communities, we can begin ...id MIT,s Ed DeLong, who led the research team. "Th...
...e of real estate may be its most important feature...at the University of California, San Diego (UCSD) ...the location of genes and other features distribut...rganisms also is fundamentally important to how mi... 13 online in PLoS Computational Biology, the rese...
...y from the forthcoming issue of The American Natur...ce of two forms of females in many diving beetle p...ions for theories of sexual conflict, which arises...iffer for males and females. , "The male versus ...ehaviors, chemicals, etc.) for control over mating...
Other Biology News:Sequencing our seas 2Sequencing our seas 3Patterns in genome organization may partially explain how microbial cells work 2Patterns in genome organization may partially explain how microbial cells work 3
...tent Yeast Cells are designed for use with the Pro...strain MaV203 contains deletions in the endogenous...hybrid systems. The strain also has leu2 and trp1 ...vectors. MaV203 contains three GAL4 inducible repo...
Mouse Anti-Human Spastin Monoclonal Antibody, Unconjugated, Clone Sp 3G11/1 from Santa Cruz Biotechnology, Inc.
Rabbit Anti-Cullin-1 Polyclonal Antibody, Unconjugated from AnaSpec
HyperMu Transposon from EPICENTRE Biotechnologies
Biology Products: